Holen Sie sich die Stockscreener-App
143.00
0.52%
0.74
Vorhandelsmarkt:
144.72
1.72
+1.20%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BIIB?
Forum
Prognose
Aktiensplit
Biogen Inc Aktie (BIIB) Neueste Nachrichten
J.L. Bainbridge Exits Most of Biogen Stake as Biotech Stock Eyes Turnaround - The Motley Fool
Is a relief rally coming for Biogen Inc. holdersTrade Volume Report & Smart Allocation Stock Reports - newser.com
Is Biogen Inc. stock a top momentum playLong Setup & Technical Pattern Alert System - newser.com
Is Biogen Inc. stock a safe buy before earningsWeekly Gains Report & Reliable Volume Spike Trade Alerts - newser.com
Sector ETF performance correlation with Biogen Inc.Market Rally & Reliable Breakout Forecasts - newser.com
New York State Teachers Retirement System Has $13.90 Million Stock Holdings in Biogen Inc. $BIIB - MarketBeat
Ritholtz Wealth Management Buys Shares of 6,076 Biogen Inc. $BIIB - MarketBeat
Will LEQEMBI IQLIK’s At-Home Launch Redefine Biogen’s (BIIB) Alzheimer’s Treatment Story? - simplywall.st
Is it time to cut losses on Biogen Inc.2025 Buyback Activity & Fast Gain Swing Alerts - newser.com
Is Biogen Inc. stock a buy before product launchesQuarterly Growth Report & Smart Swing Trading Alerts - nchmf.gov.vn
Applied Finance Capital Management LLC Invests $465,000 in Biogen Inc. $BIIB - MarketBeat
TD Asset Management Inc Has $17.96 Million Holdings in Biogen Inc. $BIIB - MarketBeat
Yousif Capital Management LLC Has $2.48 Million Stock Holdings in Biogen Inc. $BIIB - MarketBeat
Is Biogen Inc. stock a defensive play in 20252025 Historical Comparison & AI Forecast Swing Trade Picks - nchmf.gov.vn
How Biogen Inc. stock compares to market leadersTreasury Yields & Reliable Trade Execution Plans - nchmf.gov.vn
Using portfolio simulators with Biogen Inc. includedQuarterly Trade Review & Stock Market Timing Techniques - newser.com
Biogen (BIIB) Gains Momentum with Patient Opportunity Equity Str - GuruFocus
Key metrics from Biogen Inc.’s quarterly dataPortfolio Gains Report & Daily Growth Stock Investment Tips - newser.com
Wedbush Has Optimistic Outlook of Biogen Q1 Earnings - MarketBeat
Allianz Asset Management GmbH Has $66.19 Million Position in Biogen Inc. $BIIB - MarketBeat
Cwm LLC Acquires 6,639 Shares of Biogen Inc. $BIIB - MarketBeat
Callan Family Office LLC Purchases Shares of 2,454 Biogen Inc. $BIIB - MarketBeat
Biogen Inc. Stock Falls by 3.65% - Idéal Investisseur
Is Biogen Now an Opportunity After Recent 25% Share Price Decline? - simplywall.st
Alzheimer's Disease Market: Epidemiology, Therapies, - openPR.com
Wedbush Comments on Biogen's FY2025 Earnings (NASDAQ:BIIB) - MarketBeat
Hourglass Capital LLC Purchases Shares of 17,970 Biogen Inc. $BIIB - MarketBeat
Looking at the Changing Narrative for Biogen After Recent Pipeline and Market Developments - Yahoo Finance
Generali Asset Management SPA SGR Purchases 2,518 Shares of Biogen Inc. $BIIB - MarketBeat
NorthRock Partners LLC Invests $391,000 in Biogen Inc. $BIIB - MarketBeat
US Bancorp DE Sells 8,837 Shares of Biogen Inc. $BIIB - MarketBeat
3 Reasons BIIB is Risky and 1 Stock to Buy Instead - The Globe and Mail
Biogen Inc. stock outperforms competitors on strong trading day - MSN
(BIIB) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com
Biogen Inc (IDP.SG) stock price, news, quote and history - Yahoo
When is the best time to exit Biogen Inc.July 2025 Review & Capital Protection Trading Alerts - newser.com
Wedbush Forecasts Biogen's Q3 Earnings (NASDAQ:BIIB) - MarketBeat
Autoinjectors Market 2025: Industry Drug Delivery, Smart - openPR.com
Vanguard Personalized Indexing Management LLC Has $4.39 Million Position in Biogen Inc. $BIIB - MarketBeat
Is Biogen Inc. (IDP) stock a buy on weaknessPortfolio Update Report & Real-Time Chart Pattern Alerts - newser.com
Biogen (BIIB) to Report Q3 Earnings Amid IPR&D Expense Impact - GuruFocus
Biogen (BIIB) Valuation: Assessing Market Discount After Recent Signs of Financial Stabilization - simplywall.st
Biogen sees negative impact on Q3 EPS from IPR&D expense - Seeking Alpha
Biogen expects $2 million research and development expense in Q3 2025 - Investing.com India
Biogen expects estimated charge to impact net income per diluted share for Q3 by $-0.01 - MarketScreener
CD40 Targeting Therapy Clinical Trials Anti CD40 Antibody Therapy Market Opportunity Assessment Insight - GlobeNewswire Inc.
Biogen (NASDAQ:BIIB) Price Target Raised to $135.00 - MarketBeat
Wedbush Raises Price Target on Biogen to $135 From $129, Keeps Neutral Rating - MarketScreener
LEQEMBI(R) IQLIK(TM) (lecanemab-irmb) Subcutaneous Autoinjector Named to TIME's "Best Inventions of 2025" - ACN Newswire
Aberdeen Group plc Purchases 9,942 Shares of Biogen Inc. $BIIB - MarketBeat
Can Biogen Inc. stock double in next 5 yearsProduct Launch & Stepwise Entry/Exit Trade Alerts - newser.com
Volatility clustering patterns for Biogen Inc.Weekly Profit Analysis & Real-Time Sentiment Analysis - newser.com
1 Healthcare Stock to Research Further and 2 We Find Risky - FinancialContent
[8-K] – BIOGEN INC. (BIIB) (CIK 0000875045) | BIIB SEC FilingForm 8-K - Stock Titan
Eisai and Biogen's LEQEMBI IQLIK™ Named One of TIME's "Best Inventions of 2025" for Alzheimer's Treatment - Quiver Quantitative
1.20%
3.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):